We are live on ! Find out more
PIP

Palisades Investment Partners Portfolio holdings

AUM $352M
1-Year Est. Return 76.79%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+76.79%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$25.9M
Cap. Flow
+$8.53M
Cap. Flow %
3.35%
Top 10 Hldgs %
48.61%
Holding
51
New
12
Increased
30
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$9.28M
2
ROOT icon
Root
ROOT
+$8.56M
3
PAYS icon
Paysign
PAYS
+$5.74M
4
PKE icon
Park Aerospace
PKE
+$5.26M
5
IESC icon
IES Holdings
IESC
+$4.58M

Top Sells

Rank Stock Value
1
INOD icon
Innodata
INOD
+$18.2M
2
ADMA icon
ADMA Biologics
ADMA
+$7.26M
3
SWTX
SpringWorks Therapeutics
SWTX
+$6.23M
4
ARDX icon
Ardelyx
ARDX
+$2.78M
5
STRL icon
Sterling Infrastructure
STRL
+$831K

Sector Composition

Rank Sector Weight
1 Industrials 37.89%
2 Technology 19.97%
3 Healthcare 18.34%
4 Financials 13.37%
5 Consumer Discretionary 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWTX
51
DELISTED
SpringWorks Therapeutics
SWTX
– –
-132,555
Closed -$6.23M
1 2
3

Similar funds

ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
BL
BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Palisades Investment Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Palisades Investment Partners held 51 positions worth $255M, up 11% from $229M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Palisades Investment Partners deployed $8.53M of net new capital in Q3 2025, opening 12 new positions and adding to 30 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 40,433 shares worth $9.78M.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Innodata, an estimated $18.2M trimmed.

  • Palisades Investment Partners's largest Q3 2025 buy was iShares Russell 2000 ETF: 40,433 shares worth $9.78M.
  • Palisades Investment Partners added most to SPX Corp in Q3 2025, an estimated $264K increase.
  • Palisades Investment Partners's biggest Q3 2025 reduction was Innodata, cutting an estimated $18.2M.
  • Palisades Investment Partners fully exited ADMA Biologics in Q3 2025, selling an estimated $7.26M.
  • Palisades Investment Partners's ten largest holdings make up 49% of its $255M portfolio in Q3 2025.
  • Palisades Investment Partners opened 12 new positions and closed 2 in Q3 2025.
  • Palisades Investment Partners's portfolio value rose 11% quarter-over-quarter to $255M.

Based on Palisades Investment Partners's 13F filing for Q3 2025, filed 30 Oct 2025.